fda restrictions bpc-157 compounding advisory committee votes to add popular peptide to drug list Regulatory Alert: FDA's April 2026

Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! FDA Panel Votes to Recommend BPC 157 for Pharmacy Compounding HealingMaps

SKU: 60434939653 · From uqtrucking.com